pubrio
Sanyou Biopharmaceuticals logo

Sanyou Biopharmaceuticals

Privately Held
sanyoubio.com
バイオテクノロジー研究200+ employeesFounded 2015🇺🇸 アメリカ合衆国

Sanyou Biopharmaceuticals is a high-tech biopharmaceutical company driven by the mission of “To make it easy to develop new drugs worldwide”. The company is committed to fundamentally addressing the key challenges at the source of innovative drug development. Powered by its AI-STAL and supported by Sanyou Al-Drug Accelerator(SAI-DA), Sanyou provides comprehensive, one-stop solutions for innovative drug discovery, with a particular focus on molecular discovery and selection. Sanyou Bio has been dedicated to developing a world-class innovative biological drug R&D hub and to working collaboratively with partners worldwide to accelerate the development of innovative therapeutics. Headquartered in Shanghai, China, Sanyou has established global business centers across Asia, North America, and Europe, forming an international business network. The company currently operates and has planned over 20,000 square meters of R&D and GMP facilities. Sanyou has established strong collaborations with more than 2,000 pharmaceutical and biotech companies worldwide, empowering over 1,200 new drug discovery and development projects. It has completed more than 50 collaboration projects, over 10 of which have advanced to IND approval and clinical development stages. The company has filed over 170 invention patents, with more than 30 granted. It has also obtained over 10 national and international qualifications and system certifications, including National High-Tech Enterprise, Shanghai “Specialized and Innovative” Enterprise, ISO9001, and ISO27001.

設立年
2015
従業員数
200+
業種
バイオテクノロジー研究
企業タイプ
Privately Held
本社
🇺🇸Cambridge (+4)
専門分野
健康とウェルネス研究開発バイオテクノロジー研究バイオ産業

拡大インテリジェンス

NEW · Pubrio 限定

Sanyou Biopharmaceuticals の市場拡大を追跡しています

グローバル展開

ライブ
ステージ
検討中投資中参入中稼働中

アクティビティパルス

過去 90 日間に 3 件のシグナル。

過去 90 日間
採用
0
アクティビティなし
マーケティング・PR
0
アクティビティなし
プロダクト・技術
3↑ +100%
製品ローンチ
+2さらにカテゴリロック中
5件中3件を表示
知っておきたい情報

Sanyou Biopharmaceuticals に関するよくある質問

Sanyou Biopharmaceuticals の事業、市場、成長シグナルに関する簡潔な回答。

Sanyou Biopharmaceuticals is a high-tech biopharmaceutical company driven by the mission of “To make it easy to develop new drugs worldwide”. The company is committed to fundamentally addressing the key challenges at the source of innovative drug development. Powered by its AI-STAL and supported by Sanyou Al-Drug Accelerator(SAI-DA), Sanyou provides comprehensive, one-stop solutions for innovative drug discovery, with a particular focus on molecular discovery and selection. Sanyou Bio has been dedicated to developing a world-class innovative biological drug R&D hub and to working collaboratively with partners worldwide to accelerate the development of innovative therapeutics. Headquartered in Shanghai, China, Sanyou has established global business centers across Asia, North America, and Europe, forming an international business network. The company currently operates and has planned over 20,000 square meters of R&D and GMP facilities. Sanyou has established strong collaborations with more than 2,000 pharmaceutical and biotech companies worldwide, empowering over 1,200 new drug discovery and development projects. It has completed more than 50 collaboration projects, over 10 of which have advanced to IND approval and clinical development stages. The company has filed over 170 invention patents, with more than 30 granted. It has also obtained over 10 national and international qualifications and system certifications, including National High-Tech Enterprise, Shanghai “Specialized and Innovative” Enterprise, ISO9001, and ISO27001.

今日から旅を始めましょう

まずはプラットフォームでも、まずは会話からでも

Pubrio を自分で使うことも、リサーチ・リード獲得・データ連携を私たちに任せることもできます。

チームに相談
Start Journey Image
pubrio

Pubrio は 50 以上のローカルソースからビジネス・人物・インテントデータを統合し、AI と収益チームに市場全体の可視性を提供します。

© 2026 Pubrio. 無断転載を禁じます。